Insilico Medicine - Company info. interviews, news

<!DOCTYPE html> <html lang="en"> <head> <meta charset="UTF-8"> <title> Insilico Medicine - Company info. interviews, news </title> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <link rel="canonical" href="https://www.biopharmatrend.com/m/company/insilico-medicine/" />  <script async src="https://www.googletagmanager.com/gtag/js?id=G-YK7FCK71TD"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-YK7FCK71TD'); </script> <link rel="stylesheet" type="text/css" href="/static/css/marketplace.9b06f2a8dc19.css" /> <meta name="description" content="InSilico Medicine is a globally leading generative AI-driven biotech company in terms of AIDD pipeline progress providing end-to-end solutions. Found…" />  <meta name="twitter:card" content="summary_large_image"> <meta name="twitter:title" content="Insilico Medicine"> <meta name="twitter:description" content="InSilico Medicine is a globally leading generative AI-driven biotech company in terms of AIDD pipeline progress providing end-to-end solutions. Found…"> <meta name="twitter:image" content="https://www.biopharmatrend.com/files/companies/logo-company-15.jpg">  <meta property="og:type" content="article" /> <meta property="og:url" content="https://www.biopharmatrend.com/m/company/insilico-medicine/" /> <meta property="og:title" content="Insilico Medicine" /> <meta property="og:description" content="InSilico Medicine is a globally leading generative AI-driven biotech company in terms of AIDD pipeline progress providing end-to-end solutions. Found…" /> <link rel="shortcut icon" href="/static/favicon.ab1145f4d518.ico" /> <link rel="stylesheet" type="text/css" href="/static/css/main.6dead4e2266d.css" /> <style type="text/css"> article.company-page { background: white; border: 1px #bcb solid; border-radius: 4px; padding: 1rem; } .well ul > li { margin-bottom: 0.5rem; } .rating-block { background: khaki; background-image: linear-gradient(to right, khaki, khaki, darkkhaki); padding: 0.25em 1em; color: black; } </style> </head> <body> <div id="main-preheader"> <div class="container block-preheader"> <div id="logo-top"> <a href="/"><b>BioPharmaTrend</b></a>  </div> <div class="burger-container"> <div class="burger-button-container"> <button type="button" class="burger-button" onclick="document.documentElement.classList.toggle('blockfix');this.parentElement.parentElement.classList.toggle('active');"> <div class="burger-line burger-line-1"></div> <div class="burger-line burger-line-2"></div> <div class="burger-line burger-line-3"></div> </button> </div>  <div id="main-search-menu"> <div class="top-search"> <form action="/search/" class="top-search-form"> <button type="submit" class="btn btn-default"><i class="glyphicon glyphicon-search"></i></button> <input type="text" name="q" value="" size="10" class="form-control form-control-inline" required="" placeholder="e.g. 'quantum tech' or 'stem cell'"> <input type="hidden" name="section" value="insights"> </form> <span class="top-search-switcher button" onclick="this.parentElement.classList.toggle('active')"> <span class="glyphicon glyphicon-search"></span> <span class="glyphicon glyphicon-remove"></span> </span> </div> <span class="top-search-switcher button"> <span class="glyphicon glyphicon-search"></span> </span> </div>  <nav id="main-menu"> <div class="mobile-menu-item"> <a class="top-menu-link mobile-menu-item-title" href="/section/news/"><b>Latest News</b></a> </div> <div class="mobile-menu-item"> <b class="mobile-menu-item-title" onclick="this.parentElement.classList.toggle('active')">All Topics <span class="caret"></span></b> <div class="sub-menu-container"> <ul class="sub-menu"> <li><a class="top-menu-link" href="/topic/bioeconomy-society/">Bioeconomy & Society</a></li> <li><a class="top-menu-link" href="/topic/ai-digital/">AI & Digital</a></li> <li><a class="top-menu-link" href="/topic/startups/">Startups & Deals</a></li> <li><a class="top-menu-link" href="/topic/neurotech/">NeuroTech</a></li> <li><a class="top-menu-link" href="/topic/clinical-trials/">Clinical Trials</a></li> <li><a class="top-menu-link" href="/topic/synbio/">Biotech</a></li> <li><a class="top-menu-link" href="/topic/tools-methods/">Tools & Methods</a></li> <li><a class="top-menu-link" href="/topic/healthtech/">HealthTech</a></li> <li><a class="top-menu-link" href="/topic/aging-research/">Aging & Longevity</a></li> <li><a class="top-menu-link" href="/topic/contract-research/">Contract Research</a></li> <div class="sub-menu-margin"></div>  <li><a class="top-menu-link" href="/section/latest/">Latest insights</a></li> <li><a class="top-menu-link" href="/premium-content/">Premium Content</a></li> <div class="sub-menu-margin" style="border-bottom: 1px solid limegreen;"></div> <li><a class="top-menu-link" href="/knowledge-center/">Knowledge Center</a></li> </ul> </div> </div> <div class="mobile-menu-item"> <a class="top-menu-link mobile-menu-item-title" href="/section/interviews/"><b>Interviews</b></a> </div>  <div class="mobile-menu-item"> <b class="mobile-menu-item-title" onclick="this.parentElement.classList.toggle('active')">Companies <span class="caret"></span></b> <div class="sub-menu-container"> <ul class="sub-menu">  <li><a class="top-menu-link" href="/m/marketplace/">Company Directory</a></li> <li><a class="top-menu-link" href="/section/interviews/">Interviews with Thought Leaders</a></li> <li><a class="top-menu-link" href="/section/case-studies/">Sponsored Case Studies</a></li> <li><a class="top-menu-link" href="/m/editor-tool/">Create Company Profile</a></li> </ul> </div> </div> <div class="mobile-menu-item"> <b class="mobile-menu-item-title" onclick="this.parentElement.classList.toggle('active')">More <span class="caret"></span></b> <div class="sub-menu-container"> <ul class="sub-menu"> <li><a class="top-menu-link" href="/about/">About Us</a></li> <li><a class="top-menu-link" href="/about/team/">Our Team</a></li> <li><a class="top-menu-link" href="/about/advisory-board/">Advisory Board</a></li> <li><a class="top-menu-link" href="/about/press-citations/">Citations and Press Coverage</a></li> <li><a class="top-menu-link" href="/events/">Partner Events Calendar</a></li> <li><a class="top-menu-link" href="/advertising-media-kit/">Advertise with Us</a></li> <li><a class="top-menu-link" href="/contributor/">Write for Us</a></li> </ul> </div> </div> </nav> </div> <div id="main-user-actions">  <div class="mobile-menu-item"> <a href="/membership/" class="button-subscribe top-menu-link">Subscribe</a> </div>  <div class="mobile-menu-item last"> <a href="#" class="mobile-menu-item-title" rel="nofollow" title="Login/Join" onclick="document.getElementById('login-popup').classList.toggle('hidden')"> <span class="glyphicon glyphicon-log-in"></span> <span class="mobile-hide-m">Login/Join</span> </a> </div> </div> </div> </div> <div id="main-preheader-margin"></div> <div id="sencondary-menu-block"> <div class="container clearfix"> <nav> <ul class="text-center"> <li><a href="/topic/ai-digital/">AI & Digital</a></li> <li><a href="/topic/startups/">Startups & Deals</a></li> <li><a href="/topic/neurotech/">NeuroTech</a></li> <li><a href="/topic/clinical-trials/">Clinical Trials</a></li> <li><a href="/topic/synbio/">Biotech</a></li> <li><a href="/topic/tools-methods/">Tools & Methods</a></li> </ul> </nav> </div> </div>  <div id="main-content" class="container"> <main id="content" class="col-lg-9 col-md-8 col-sm-12 col-xs-12"> <div style="margin-bottom: 1rem"> back to <a href="/m/marketplace/"><strong>Directory</strong></a> </div> <article class="company-page"> <header><h3>Insilico Medicine </h3></header> <div id="comp-overview"> <div class="blockfix row"> <div class="col-lg-4"> <p><img src="/files/companies/logo-company-15.jpg" alt="Insilico Medicine logo" /></p> <section> <div class="tag" style="max-width: 100%;"> Website<br> <a href="https://insilico.com/" rel="nofollow" target="_blank" title="https://insilico.com/" style="max-width: 100%;overflow: hidden;display: inline-block;white-space: nowrap;text-overflow: ellipsis;"> <b>https://insilico.com/</b></a> </div> <div class="tag"> Founded<br> <b style="color:#430">2014</b> </div> </section> <section> <div class="tag"> Patents<br> <b>12</b> </div> <div class="tag"> Publications<br> <b>160</b> </div> </section> <br> <section> <h4>Technologies</h4> <a href="/m/marketplace/?mc_10=97" class="tag">AI Companies (Drug Discovery)</a> </section> <br> </div> <div class="col-lg-8"> <div><p>InSilico Medicine is a globally leading generative AI-driven biotech company in terms of AIDD pipeline progress providing end-to-end solutions. Founded in 2014 at the Emerging Technology Centers of Johns Hopkins University in Baltimore, Maryland, the company has a global presence in the U.S., Greater China, Canada, and the Middle East.</p> <p>By leveraging the company’s rapidly evolving, proprietary Pharma.AI platform across biology, chemistry and clinical development, the company aims at a mission to accelerate drug discovery and development. Pharma.AI platform consisting of Biology42, Chemistry42 and Medicine42, which are designed to be integrated across the drug discovery and development process to efficiently identify novel drug targets, design de novo molecules against both novel and known targets and optimize clinical development.</p></div> <p> <span class="tag">reinforcement learning</span> <span class="tag">drug development</span> <span class="tag">Generative adversarial networks</span> <span class="tag">biomarker development</span> <span class="tag">longevity</span> <span class="tag">aging</span> </p> </div> </div> </div> </article>  <section> <h3>Interviews</h3> <div class="posts-container-grid-3"> <article id="post-350" class="post-preview post-flex-item"> <div class="post-img-container"><a href="/post/350-alex-zhavoronkov-linking-chemistry-and-biology-using-artificial-intelligence/"> <img alt="" src="/files/blog/post-cover-350.png" class="post-preview-img"> </a></div> <h5><a href="/post/350-alex-zhavoronkov-linking-chemistry-and-biology-using-artificial-intelligence/"> Alex Zhavoronkov: Linking Chemistry and Biology Using Artificial Intelligence </a></h5> </article> <article id="post-48" class="post-preview post-flex-item"> <div class="post-img-container"><a href="/post/48-interview-the-current-status-of-ai-in-drug-discovery-and-looking-forward-into-2018/"> <img alt="[Interview] The Current Status Of AI In Drug Discovery And Looking Forward Into 2018" src="/files/blog/20180619_125402.7799_alexzhavoronkov-exponential-medicine.jpg" class="post-preview-img"> </a></div> <h5><a href="/post/48-interview-the-current-status-of-ai-in-drug-discovery-and-looking-forward-into-2018/"> [Interview] The Current Status Of AI In Drug Discovery And Looking Forward Into 2018 </a></h5> </article> </div> </section>  <hr> <section> <h3>Posts Mentioning This Company</h3> <article id="post-583" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/583-building-momentum-for-global-ai-driven-longevity-transformation/"> <img alt="" src="/files/blog/post-cover-583.jpg" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/583-building-momentum-for-global-ai-driven-longevity-transformation/"> Building Momentum for Global AI-driven Longevity Transformation </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>Aug. 10, 2022</time>   </footer> Today, Insilico Medicine, a leading player in artificial intelligence (AI)-driven drug discovery and longevity research, tops up its recent $60 million Series D with additional $35 million from Prosperity7 Ventures, a global VC fund by Saudi Arabia’s giant Aramco. This investment by Aramco is yet another step within Saudi Arabia’s … </div> </div> </article> <article id="post-999" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/999-key-trends-in-aging-research-where-are-we-now/"> <img alt="" src="/files/blog/post-cover-999.webp" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/999-key-trends-in-aging-research-where-are-we-now/"> Key Trends in Aging Research: Where Are We Now? </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>Nov. 1, 2024</time>   </footer> Over the past decade, aging research has transitioned from foundational biological studies, including a landmark introduction of 9 hallmarks of aging back in 2013 and its expanded version of 12 hallmarks in 2023, to a highly technical, multidisciplinary field. This transformation has been driven by a lot of advances in … </div> </div> </article> <article id="post-725" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/725-11-biopharma-trends-to-watch-in-2024/"> <img alt="" src="/files/blog/post-cover-725_zzTEyFJ.webp" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/725-11-biopharma-trends-to-watch-in-2024/"> 11 Biopharma Trends to Watch in 2024 </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>March 14, 2024</time>   </footer> 2023 has marked a remarkable year of technological advancements in drug discovery and biotechnology. Ironically, the elation from a kaleidoscope of technological and scientific advances is in stark contrast with the overall industry’s economic performance—it was also a rough year for biopharma overall. There are signs that 2024 might be better … </div> </div> </article> <article id="post-758" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/758-innovative-life-sciences-companies-to-watch-in-2024/"> <img alt="" src="/files/blog/post-cover-758.webp" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/758-innovative-life-sciences-companies-to-watch-in-2024/"> 9 Innovative Life Sciences Companies to Watch in 2024 </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>Feb. 13, 2024</time>   </footer> The biotech and pharmaceutical industries are entering 2024 amid a wave of innovation and technological advancement.  The biopharma field is increasingly influenced by the advent of cutting-edge technologies such as artificial intelligence (AI), organ-on-a-chip systems, and gene editing therapies promising more personalized and precise treatments for a variety of conditions. </div> </div> </article> <article id="post-670" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/670-tech-first-companies-take-the-lead-in-ai-drug-discovery/"> <img alt="Top AI Drug Discovery Companies Transforming the Pharma Industry" src="/files/blog/post-cover-670.webp" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/670-tech-first-companies-take-the-lead-in-ai-drug-discovery/"> Tech-First Companies Take the Lead in AI Drug Discovery </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>Nov. 27, 2023</time>   </footer> In recent news, Recursion (NASDAQ: RXRX), a prominent clinical stage TechBio firm, has announced the signing of agreements to acquire Cyclica and Valence, two companies with expertise in AI-enabled drug discovery. These acquisitions strengthen Recursion's position in computational chemistry, machine learning, and artificial intelligence, enhancing its technology-enabled drug discovery capabilities … </div> </div> </article> <article id="post-624" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/624-10-breakthrough-technologies-of-2022/"> <img alt="" src="/files/blog/post-cover-624.jpg" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/624-10-breakthrough-technologies-of-2022/"> 2022 in Retrospect: 10 Breakthrough Technologies in Drug Discovery </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>Jan. 5, 2023</time>   </footer> Reflecting on 2022, let’s review several breakthrough technologies that are shaping the future of biology research and drug discovery. I have prepared this list based on a review of recent articles published on BiopharmaTrend -- by myself and by numerous guest authors. </div> </div> </article> <article id="post-391" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/391-rd-trends-driving-pharmaceutical-markets-in-2021-and-beyond/"> <img alt="" src="/files/blog/post-cover-391.png" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/391-rd-trends-driving-pharmaceutical-markets-in-2021-and-beyond/"> 15 Biopharma Research Trends to Watch in 2022 </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>Dec. 29, 2022</time>   </footer> Table of contents:    mRNA vaccines and RNA therapies  Epitranscriptomics Targeting RNA with small molecules Deep learning and big data in drug discovery Neoantigens Theranostics  Exosomes Synthetic Biology 3D Bioprinting Antibiotics “anti-trend” (and hope?) Nanotechnologies in Drug Delivery Gene Editing (CRISPR-Cas9) Aging research  Microbiome  Protein Degraders   Discoveries made in … </div> </div> </article> <article id="post-596" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/596-a-race-for-better-3cl-inhibitors-to-cure-covid-19-copies-vs-innovators/"> <img alt="" src="/files/blog/post-cover-596.jpg" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/596-a-race-for-better-3cl-inhibitors-to-cure-covid-19-copies-vs-innovators/"> A Race For Better 3CL Inhibitors to Cure COVID-19: Copies vs. Innovators </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>Aug. 30, 2022</time>   </footer> Disclaimer: This post is not medical advice and is for informational purposes only. All the information contained here is related to research and development and is not intended for clinical use. Never attempt to take any medications without consulting with your medical doctor.    The global COVID-19 pandemic is far … </div> </div> </article> <article id="post-589" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/589-9-companies-using-artificial-intelligence-to-fight-infectious-diseases/"> <img alt="" src="/files/blog/post-cover-589.jpg" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/589-9-companies-using-artificial-intelligence-to-fight-infectious-diseases/"> 9 Companies Using Artificial Intelligence to Fight Infectious Diseases </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>Aug. 18, 2022</time>   </footer> Development of a novel drug is a tedious process that requires immense investments of resources and time - on average, it takes at least ten years and $ 2.6 B for a new medicine to complete the journey from initial discovery to the marketplace. And then patents give pharmaceutical companies … </div> </div> </article> <article id="post-475" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/475-ai-helps-discover-potential-first-in-class-molecule-for-immuno-oncology/"> <img alt="" src="/files/blog/post-cover-475.jpg" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/475-ai-helps-discover-potential-first-in-class-molecule-for-immuno-oncology/"> AI Helps Discover Potential First-in-class Molecule for Immuno-oncology for Fosun Pharma </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>Feb. 18, 2022</time>   </footer> The global artificial intelligence (AI) leader Insilico Medicine announced its first milestone in cancer immunotherapy for their external collaboration with Fosun Pharmaceuticals (600196.SH, 02196.HK), an international healthcare group in China. In under 40 days since the collaboration announcement, companies nominated the first preclinical drug candidate ISM004-1057D, a potential first-in-class small … </div> </div> </article> <article id="post-397" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/397-pharmaceutical-artificial-intelligence-in-2021-key-developments-so-far/"> <img alt="" src="/files/blog/post-cover-397_5pUI7Is.png" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/397-pharmaceutical-artificial-intelligence-in-2021-key-developments-so-far/"> Pharmaceutical AI in 2021: Key Developments So Far </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>Aug. 9, 2021</time>   </footer> Table of Contents:   Introduction Artificial intelligence (AI) in drug discovery yields breakthroughs The abundance of venture capital, major funding rounds IPOs of AI Pharma Companies in 2021 New AI-driven biotech startups founded in 2020 Notable AI-focused collaborations involving “big pharma” players AI adoption by the contract research organizations (CROs)  … </div> </div> </article> <article id="post-292" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/292-cros-tap-into-ai-to-increase-value-proposition/"> <img alt="CROs Tap Into AI To Increase Value Proposition" src="/files/blog/post-cover-292.png" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/292-cros-tap-into-ai-to-increase-value-proposition/"> Contract Research Organizations Tap Into AI To Increase Value Proposition </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>Feb. 11, 2021</time>   </footer> A few decades ago, pharmaceutical giants did most of the discovery work in-house, along with every other work necessary to get a drug or medical device to market. Nowadays, nearly any type of R&D or regulatory filing work that a drug maker or a medical-device producer needs to do -- … </div> </div> </article> <article id="post-206" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/206-the-increasing-potential-of-virtual-reality-in-drug-design/"> <img alt="The Increasing Potential of VR in Drug Design" src="/files/blog/post-2020-06-19_2QkgLgo.png" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/206-the-increasing-potential-of-virtual-reality-in-drug-design/"> The Increasing Potential of Virtual Reality in Drug Design </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>June 19, 2020</time>   </footer> Using virtual reality (VR) for manipulating 3D models of molecules in the context of drug design is an emerging technological opportunity, which increasingly grabs attention among scientists at biotech startups, and larger pharmaceutical organizations.  </div> </div> </article> <article id="post-139" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/139-how-pharma-reacts-to-wuhan-coronavirus-outbreak/"> <img alt="Pharma Companies Race To Tackle Wuhan Coronavirus Outbreak" src="/files/blog/20200128_183200.7064_coronavirus_post.png" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/139-how-pharma-reacts-to-wuhan-coronavirus-outbreak/"> How Pharma Reacts To Wuhan Coronavirus Outbreak </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>March 14, 2020</time>   </footer> UPDATE April 04. 2020. The number of confirmed cases of COVID19 approaches 1M globally. Since too many drug repurposing programs and vaccine development projects have been urgently initiated, we decided to summarize them in a separate post: A Running List Of COVID-19 Treatments And Vaccines In Development With this, we … </div> </div> </article> <article id="post-90" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/90-artificial-intelligence-yields-early-results-in-drug-discovery/"> <img alt="Artificial Intelligence Yields Early Results in Drug Discovery" src="/files/blog/20190721_153246.5568_36.png" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/90-artificial-intelligence-yields-early-results-in-drug-discovery/"> Artificial Intelligence Yields Early Results in Drug Discovery </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>April 7, 2019</time>   </footer> A historically significant milestone has just been reached by Oxford, UK-based Exscientia, which used its artificial intelligence (AI)-based drug discovery platform Centaur Chemist™ to deliver the first drug candidate in the framework of their multiyear collaboration with GSK. This AI-derived small molecule is a highly potent in vivo active substance … </div> </div> </article> <article id="post-70" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/70-healthcare-ai-industry-consolidates-to-accelerate-progress-a-global-alliance-announced-in-washington-dc/"> <img alt="Pharma and Healthcare AI Vendors Join Forces To Accelerate Progress In Drug Discovery" src="/files/blog/20180912_123606.6890_AAIH.png" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/70-healthcare-ai-industry-consolidates-to-accelerate-progress-a-global-alliance-announced-in-washington-dc/"> Pharma and Healthcare AI Vendors Join Forces To Accelerate Progress In Drug Discovery </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>Sept. 12, 2018</time>   </footer> Today Basel is crowded with some of the top business and research leaders representing a young and rapidly growing industry of artificial intelligence (AI) in healthcare and pharmaceutical research. They come together to announce mission and launch activities of a global Alliance for Artificial Intelligence in Healthcare (AAIH), which is … </div> </div> </article> <article id="post-56" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/56-navigating-real-chemical-space-in-a-pursuit-of-novel-medicines/"> <img alt="How To Discover “Stars” In Chemical "Cosmos"" src="/files/blog/20190721_142842.1165_4.png" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/56-navigating-real-chemical-space-in-a-pursuit-of-novel-medicines/"> Navigating In REAL Chemical Space To Find Novel Medicines (Now 3.8 Billion Molecules) </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>July 27, 2018</time>   </footer> [Latest update: 27.07.2018] February 6 2018 will be marked in history as the day when an automobile embarked on a million year trip into far space. On that day, Falcon Heavy, the 230ft megarocket, successfully launched from Cape Canaveral, Florida, bringing on board Elon Musk’s personal Tesla Roadster with a crash … </div> </div> </article> <article id="post-53" class="post-preview well"> <div class="row"> <div class="col-lg-4"> <div class="post-img-container"><a href="/post/53-2018-brings-surge-of-activity-in-the-ai-for-drug-discovery-space/"> <img alt="2018 Brings A Surge Of Activity In The “AI For Drug Discovery” Space" src="/files/blog/20190721_145225.7517_13.png" class="post-preview-img"> </a></div> </div> <div class="col-lg-8"> <h4><a href="/post/53-2018-brings-surge-of-activity-in-the-ai-for-drug-discovery-space/"> 2018 Brings A Surge Of Activity In The “AI For Drug Discovery” Space </a></h4> <footer class="post-meta"> <span class="glyphicon glyphicon-calendar"></span> <time>March 15, 2018</time>   </footer> (Last updated: 15.03.2018) The idea of using artificial intelligence (AI) to accelerate drug discovery process and boost a success rate of pharmaceutical research programs has inspired a notable amount of activity over the last several years with a considerable number of initiated research collaborations between AI-driven R&D vendors and top … </div> </div> </article> </section> </main> <aside id="main-sidebar" class="col-lg-3 col-md-4 col-sm-12 col-xs-12"> <p> </p>   <div class="well"> <h3>News</h3> <ul class="list-unstyled"> <li> <small>2024-11-12</small><br> <a href="/post/1018-ai-driven-drug-shows-promising-phase-iia-results-in-treating-fatal-lung-disease/"><strong>AI-Driven Drug Shows Promising Phase IIa Results in Treating Fatal Lung Disease</strong></a> </li> <li> <small>2024-10-31</small><br> <a href="/post/995-nsilico-medicine-and-sanofi-report-ai-enabled-milestone-in-drug-discovery-for-oncology/"><strong>Insilico Medicine and Sanofi Report AI-Enabled Milestone in Drug Discovery for Oncology</strong></a> </li> <li> <small>2024-09-19</small><br> <a href="/post/953-insilico-medicine-reports-positive-phase-iia-results-for-ai-designed-drug-targeting-idiopathic-pulmonary-fibrosis/"><strong>Insilico Medicine Reports Positive Phase IIa Results for AI-Designed Drug Targeting Idiopathic Pulmonary Fibrosis</strong></a> </li> <li> <small>2024-08-09</small><br> <a href="/post/895-insilico-medicines-ai-designed-tead-inhibitor-receives-ind-approval-and-orphan-drug-designation-from-fda/"><strong>Insilico Medicine's AI-Designed TEAD Inhibitor Receives IND Approval and Orphan Drug Designation from FDA</strong></a> </li> <li> <small>2024-07-23</small><br> <a href="/post/873-insilico-medicine-unveils-ai-assistant-for-medical-research-drafting/"><strong>Insilico Medicine Unveils AI Assistant for Medical Research Drafting</strong></a> </li> <li> <small>2024-05-17</small><br> <a href="/post/805-insilico-medicine-initiates-phase-i-clinical-trial-for-novel-qpctl-inhibitor/"><strong>Insilico Medicine Initiates Phase I Clinical Trial for Novel QPCTL Inhibitor</strong></a> </li> <li> <small>2024-05-02</small><br> <a href="/post/794-insilico-medicine-relocates-headquarters-to-cambridge-massachusetts/"><strong>Insilico Medicine Relocates Headquarters to Cambridge, Massachusetts</strong></a> </li> <li> <small>2024-04-03</small><br> <a href="/post/779-new-landmark-report-unveils-a-decade-of-ai-transformation-in-drug-discovery/"><strong>New Landmark Report Unveils a Decade of AI Transformation in Drug Discovery</strong></a> </li> <li> <small>2024-02-22</small><br> <a href="/post/762-using-quantum-enhanced-ai-to-design-novel-kras-inhibitors/"><strong>Using Quantum-Enhanced AI to Design Novel KRAS Inhibitors</strong></a> </li> <li> <small>2024-02-21</small><br> <a href="/post/761-a-novel-cancer-therapy-targeting-kif18a-with-ai-designed-compound/"><strong>A Novel Cancer Therapy Targeting KIF18A with AI-Designed Compound</strong></a> </li> <li> <small>2024-01-04</small><br> <a href="/post/729-menarini-group-and-insilico-medicine-forge-partnership-for-novel-cancer-therapy-development/"><strong>Menarini Group and Insilico Medicine Forge Partnership for Novel Cancer Therapy Development</strong></a> </li> <li> <small>2022-07-08</small><br> <a href="/post/559-ai-hunt-for-als-treatment-continues-with-28-novel-targets-revealed-by-insilico-medicine/"><strong>AI Hunt for ALS Treatment Continues With 28 Novel Targets Revealed by Insilico Medicine</strong></a> </li> <li> <small>2022-06-06</small><br> <a href="/post/525-insilico-medicine-snaps-up-60m-to-create-robotized-lab-of-the-future/"><strong>Insilico Medicine Snaps Up $60M to Create Robotic Lab of the Future</strong></a> </li> <li> <small>2022-05-25</small><br> <a href="/post/513-gearing-ai-to-fight-pandemics-a-novel-covid-19-drug-candidate-announced/"><strong>Gearing AI to Fight Pandemics: a Novel COVID-19 Drug Candidate Announced</strong></a> </li> </ul> </div> </aside> </div> <footer id="main-footer"><div class="container"> <div class="row"> <div class="col-12 col-sm-6 col-lg-3"> <h4 class="footer-logo"><span style="font-weight: 900">BiopharmaTrend</span>.com</h4> <div style="margin-bottom: 1.25em" class="footer-logo-slogan">Where Tech Meets Bio</div>  <div style="margin-bottom: 0.5em;"><a href="#main-footer" onclick="toggleMailingPopup(true)" style="color: lemonchiffon"> <img src="/static/img/sm-mail.a3210e82fe37.png" alt="mail" width="32" height="32" />  <b>Newsletter</b> </a></div> <div style="margin-bottom: 0.5em"><a href="https://www.linkedin.com/company/biopharmatrend-com/" rel="nofollow" target="_blank"> <img src="/static/img/sm-in.fb9ea368635d.png" alt="in" width="32" height="32" />  LinkedIn </a></div> <div style="margin-bottom: 0.5em"><a href="https://twitter.com/BiopharmaTrend" rel="nofollow" target="_blank"> <img src="/static/img/sm-x.9f3327271e1a.png" alt="x" width="32" height="32" />  X </a></div> <div style="margin-bottom: 0.5em"><a href="https://news.google.com/publications/CAAqBwgKMOaRugsw86zRAw?hl=en-US&gl=US&ceid=US:en" rel="nofollow" target="_blank"> <img src="/static/img/sm-gnews.ac9eb4674c84.png" alt="gnews" width="32" height="32" />  Google News </a></div> <div><a href="/rss/" rel="nofollow" target="_blank"> <img src="/static/img/sm-rss.bcd2cefd2eba.png" alt="rss" width="32" height="32" />  RSS Feed </a></div> </div> <div class="col-12 col-sm-6 col-lg-3"> <h4>About</h4> <hr> <nav> <ul class="list-unstyled"> <li><a href="/about/">What we do</a></li> <li><a href="/editorial-calendar/">Editorial Calendar</a></li> <li><a href="/about/press-citations/">Citations and Press Coverage</a></li> <li><a href="/terms-of-use/">Terms of Use</a></li> <li><a href="/privacy-policy/">Privacy Policy</a></li>  <li><a href="/about/disclaimer/">Disclaimer</a></li> </ul> </nav> </div> <div class="col-12 col-sm-6 col-lg-3"> <h4>We Offer</h4> <hr> <nav> <ul class="list-unstyled"> <li><a href="/premium-content/"><b style="color: lemonchiffon">Premium Content</b></a></li> <li><a href="/m/marketplace/">BioTech Scout</a></li> <li><a href="/our-products/">Reports</a></li> <li><a href="/section/interviews/">Interviews</a></li> <li><a href="/events/">Partner Events</a></li> <li><a href="/section/case-studies/">Case Studies</a></li> </ul> </nav> </div> <div class="col-12 col-sm-6 col-lg-3"> <h4>Opportunities</h4> <hr> <nav> <ul class="list-unstyled"> <li><a href="/membership/">Membership</a></li> <li><a href="/advertising-media-kit/">Advertise</a></li> <li><a href="/m/editor-tool/">Submit Company</a></li> <li><a href="/contributor/">Write for Us</a></li> <li><a href="/guest-blog/guidelines/">Author Guidelines</a></li> <li><a href="/a/contact/">Contact Us</a></li> </ul> </nav> </div> </div> <hr> <div class="text-right">© BPT Analytics LTD 2024</div> </div></footer> <div id="bpt-consent"><div class="container"> <div class="row"> <div class="col-12 col-md-6 col-lg-8"> We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our <a href="/cookies-policy/">cookies policy</a>. </div> <div class="col-12 col-md-6 col-lg-4 text-right"> <button class="btn btn-primary btn-sm" type="button" onclick="changeConsent('analytics')" style="white-space:unset">Agree</button> </div> </div> </div></div> <div id="login-popup" class="hidden popup"> <div class="close" onclick="this.parentElement.classList.add('hidden')"><i class="glyphicon glyphicon-remove"></i></div> <div class="popup-content" style="width: 25em;"> <form method="post" class="api-form" action="/a/login/?next=/m/company/insilico-medicine/"></form> </div> </div> <div id="subscription-popup" class="hidden popup"> <div class="close" onclick="this.parentElement.classList.add('hidden')"><i class="glyphicon glyphicon-remove"></i></div> <div id="subscription-popup-iframe" class="popup-content" style="width: 25em;"> </div> </div> <div id="scroll-top-pixel-anchor"></div> <button id="go-top" onclick="window.scrollTo({top: 20, left: 0, behavior: 'smooth'})">^</button> <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.3.1/jquery.min.js"></script> <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.4.1/js/bootstrap.min.js"></script> <script src="/static/js/main.df923d2272d3.js"></script> <script type="text/javascript"> if ( "IntersectionObserver" in window && "IntersectionObserverEntry" in window && "intersectionRatio" in window.IntersectionObserverEntry.prototype ) { let observer = new IntersectionObserver(entries => { if (entries[0].boundingClientRect.y < 0) { document.body.classList.add("scroll-top"); } else { document.body.classList.remove("scroll-top"); } }); observer.observe(document.getElementById("scroll-top-pixel-anchor")); } </script> </body> </html>

CINXE.COM

Insilico Medicine - Company info. interviews, news